Literature DB >> 6119313

Characterization of the alpha 1-adrenergic receptor subtype in a smooth muscle cell line.

L E Cornett, J S Norris.   

Abstract

We have identified in the DDT1 smooth muscle cell line a [3H]dihydroergocryptine-binding site having the characteristics of an alpha 1-adrenergic receptor. Specific binding of [3H]dihydroergocryptine to DDT1 cells grown either in monolayer or suspension culture was reversible, saturable, and of high affinity, and the binding site demonstrated stereoselectivity. [3H]Dihydroergocryptine dissociation constants of 1.4 +/- 0.2 nM and 1.4 +/- 0.3 nM were observed for suspension and monolayer cells, respectively. However, the concentration of binding sites in suspension-cultured cells (65,100 +/- 8,300 sites/cell) was significantly greater (p less than 0.001) than that found in monolayer cells (27,900 +/- 4,300 sites/cell). The order of agonist competition for the binding site was epinephrine (Ki = 0.92 +/- 0.32 microM) greater than or equal to norepinephrine (Ki = 2.2 +/- 1.0 microM) greater than isoproterenol (Ki = 137 +/- 17 microM), consistent with an alpha-adrenergic interaction. Results of competition experiments with specific antagonists prazosin (alpha 1-selective) or yohimbine (alpha 2-selective) and a computer modeling technique indicated that the alpha-adrenergic receptor of the DDT1 cell was predominantly (greater than 95%) the alpha 1-subtype.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6119313

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  A mechanism for testosterone modulation of alpha-1 adrenergic receptor expression in the DDT1 MF-2 smooth muscle myocyte.

Authors:  M Phillippe; T Saunders; S Bangalore
Journal:  Mol Cell Biochem       Date:  1991-01-16       Impact factor: 3.396

2.  Non classical, multiple-site interaction of [3H]-prazosin with the alpha 1-adrenoceptor of intact BC3H1 cells.

Authors:  F Sladeczek; C J Kirk; J Bockaert; B H Schmidt
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

3.  Glucocorticoid induction of beta-adrenergic receptors in the DDT1 MF-2 smooth muscle cell line involves synthesis of new receptor.

Authors:  J S Norris; P Brown; J Cohen; L E Cornett; P O Kohler; S L MacLeod; K Popovich; R B Robey; M Sifford; A J Syms
Journal:  Mol Cell Biochem       Date:  1987-03       Impact factor: 3.396

4.  Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor.

Authors:  S Cotecchia; D A Schwinn; R R Randall; R J Lefkowitz; M G Caron; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Beta-agonist- and prostaglandin E1-induced translocation of the beta-adrenergic receptor kinase: evidence that the kinase may act on multiple adenylate cyclase-coupled receptors.

Authors:  R H Strasser; J L Benovic; M G Caron; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

6.  alpha(1B) adrenergic receptors in gonadotrophin-releasing hormone neurones: relation to Transport-P.

Authors:  S Al-Damluji; W B Shen; S White; E A Barnard
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

7.  Photoaffinity labeling of the DDT1 MF-2 cell alpha 1-adrenergic receptor.

Authors:  L E Cornett; J S Norris
Journal:  Mol Cell Biochem       Date:  1985-05       Impact factor: 3.396

8.  Specific receptors for leukotriene C4 on a smooth muscle cell line.

Authors:  S Krilis; R A Lewis; E J Corey; K F Austen
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells.

Authors:  M Sakaue; B B Hoffman
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

10.  Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.

Authors:  V Ramkumar; W W Barrington; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.